You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Moderna focuses on mRNA technology and has several business units including prophylactic vaccines, cancer vaccines, rare diseases, systemic secreted and cell surface therapeutics, and cancer immunotherapy. |
Business Models for Each Product Line |
Moderna generates revenue through product sales, collaborations, and grants. Prophylactic vaccines, such as their COVID-19 vaccine, are sold to governments and healthcare organizations. Collaborations with other pharmaceutical companies provide milestone and royalty payments. Expenses include R&D, manufacturing, and regulatory compliance. |
Future Opportunities for Growth |
Moderna has growth opportunities in expanding its vaccine portfolio, specifically in RSV and flu vaccines. There is also potential in personalized cancer vaccines and rare disease treatments. Their ongoing investments in next-generation technologies and expanding manufacturing capabilities support growth. |
Potential Major Risks |
Risks include dependency on a few products for the majority of revenue, regulatory challenges, competitive pressure from other vaccine developers, and potential for adverse effects from mRNA therapies impacting market perception and demand. |
Learn More about Moderna:
Company Insights by Algobear (ChatGPT);
Tell me more about Moderna's latest earnings (MRNA:Nasdaq)
Who are some of Moderna's competitors? (MRNA:Nasdaq)
Are analysts bullish on Moderna? Please show it in a table format. (MRNA:Nasdaq)
Also read:
https://finance.yahoo.com/MRNA/profile
| Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Return on Assets | Return on Equity | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Current Ratio | Operating Cash Flow-Display | Operating Cash Flow-Actual | Operating Cash Flow | Levered Free Cash Flow-Display | Levered Free Cash Flow-Actual | Levered Free Cash Flow | % Held by Insiders | % Held by Institutions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.56 B | 9560000000.0 | 9.56 | 3.28 B | 3280000000.0 | 3.28 | 7.06 | 2.97 | 0.88 | 1.02 | 4.64 | -110.04% | -128.99% | -15.14% | -28.77% | 3.24 B | 3240000000.0 | 3.24 | -65.60% | -3760.0 mn | -3760000000.0 | -3.76 | -9.28 | 7.02 B | 7020000000.0 | 7.02 | 750.0 mn | 747000000.0 | 0.75 | 0.06849999999999999 | 3.67 | -3000.0 mn | -3000000000.0 | -3.0 | -3090.0 mn | -3090000000.0 | -3.09 | 7.27% | 72.84% |
source:https://finance.yahoo.com/MRNA/key-statistics
source:https://www.google.com/finance/quote/MRNA:NASDAQ
source:https://finance.yahoo.com/MRNA/analysis
source:https://finance.yahoo.com/MRNA/fair-value
source:https://www.nasdaq.com/market-activity/stocks/MRNA/price-earnings-peg-ratios
| Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|
| Upside % (high) | 76.43% | 5.99% (28.65) | 7.1% (28.95) | 67.04% (45.15) | 113.43% (57.69) | 530.67% (170.47) | 703.74% (217.25) | 1740.51% (497.49) |
| Downside % (low) | 10.65% | 2.59% (26.33) | 14.35% (23.15) | 14.35% (23.15) | 14.35% (23.15) | 14.35% (23.15) | 14.35% (23.15) | 57.31% (11.54) |
| Spread % | 65.78% | 3.4% | -7.25% | 52.68% | 99.08% | 516.32% | 689.38% | 1683.2% |
MRNA's price used for computing the stats is 27.03 as on date
| Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|
| Last Price-Trend PrevClose | -5.29% | 1.85% | 3.01% | -13.14% | -34.73% | -50.69% | -74.97% | -82.03% | |
| Last Price | 27.03 | 27.03 | 27.03 | 27.03 | 27.03 | 27.03 | 27.03 | 27.03 | 27.03 |
| Trend-Previous Close | 28.54 | 26.54 | 26.24 | 31.12 | 41.41 | 54.82 | 107.97 | 150.41 | None |
MRNA's symbol cumulative return percent is computed basis data from date
| 5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5D window |
5D Opportunity:
returns:
1.85%
(10.79%),
p.close: 26.54
entry:
29.4,
exit:
29.27,
min.ret:
0.46%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.85%
(12.16%),
p.close: 26.54
entry:
29.77,
exit:
29.87,
min.ret:
-0.36%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.85%
(9.77%),
p.close: 26.54
entry:
29.13,
exit:
29.73,
min.ret:
-2.06%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.85%
(14.95%),
p.close: 26.54
entry:
30.51,
exit:
30.31,
min.ret:
0.65%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.85%
(14.47%),
p.close: 26.54
entry:
30.38,
exit:
30.28,
min.ret:
0.32%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
returns:
1.85%
(13.46%),
p.close: 26.54
entry:
30.11,
exit:
30.09,
min.ret:
0.07%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2W window |
2W Opportunity:
returns:
3.01%
(10.77%),
p.close: 26.24
entry:
29.07,
exit:
29.33,
min.ret:
-0.91%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
3.01%
(8.41%),
p.close: 26.24
entry:
28.45,
exit:
28.86,
min.ret:
-1.46%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
3.01%
(20.79%),
p.close: 26.24
entry:
31.7,
exit:
30.28,
min.ret:
4.47%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
3.01%
(18.58%),
p.close: 26.24
entry:
31.12,
exit:
29.85,
min.ret:
4.07%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
returns:
3.01%
(19.2%),
p.close: 26.24
entry:
31.28,
exit:
30.33,
min.ret:
3.03%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1M window |
1M Opportunity:
returns:
-13.14%
(-34.44%),
p.close: 31.12
entry:
20.4,
exit:
21.5,
min.ret:
5.37%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-13.14%
(-31.55%),
p.close: 31.12
entry:
21.3,
exit:
21.52,
min.ret:
1.0%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-13.14%
(-32.48%),
p.close: 31.12
entry:
21.01,
exit:
21.62,
min.ret:
2.91%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
returns:
-13.14%
(-32.97%),
p.close: 31.12
entry:
20.86,
exit:
19.58,
min.ret:
-6.14%
Using: 1M trend, 0 Days Left
|
MRNA's symbol current price is 27.03 (-5.29%) as on . Yesterday's close was 28.54. It's return velocities are computed basis data from date .
| Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Open-High (> 1.0%) | 65.34% | 60.0% | 63.64% | 75.76% | 74.24% | 67.46% | 68.25% |
| Open-Low (> 1.0%) | 83.66% | 80.0% | 86.36% | 87.88% | 84.85% | 81.35% | 74.47% |
| Open-Close-Up (> 0.5%) | 38.84% | 40.0% | 36.36% | 40.91% | 37.12% | 36.9% | 39.42% |
| Open-Close-Down (> 0.5%) | 47.57% | 40.0% | 54.55% | 51.52% | 50.0% | 49.21% | 46.16% |
| Low-Close-Up (> 1.0%) | 76.21% | 80.0% | 77.27% | 69.7% | 71.97% | 69.44% | 70.11% |
| High-Close-Down (> 1.0%) | 75.29% | 60.0% | 86.36% | 86.36% | 84.85% | 80.16% | 73.02% |
MRNA's symbol win percent is computed basis data from date